Solutions
Pricing
Log in
Teams
Get started
Log in
Get started
Bioprinting
KL
by
kelly lam
·
1 view
·
Updated Mar 11, 2021
Share
Embed
Create your own
Chapters
00:00
Chapter 1
00:24
Chapter 2
00:48
Chapter 3
Audio Transcript
Auto-generated
00:00 - 00:03
second, there are concerns with the safety and effectiveness of
00:03 - 00:03
the treatment.
00:04 - 00:06
Most studies could only show short term success as they
00:06 - 00:09
are quite recent, and the lack of studies leave the
00:09 - 00:10
possible long term risk unknown.
00:11 - 00:14
It will also be difficult to conduct control experiment to
00:14 - 00:16
test the safety of the Barbary tissues, as we will
00:17 - 00:18
not be able to find a number of healthy individuals
00:19 - 00:22
to test them as the tissues are tailor made to
00:22 - 00:23
suit the patient's needs.
00:24 - 00:28
First, should human enhancement be allowed, this might sound something
00:28 - 00:30
that you might see in a typical Avengers movie.
00:31 - 00:33
But in the future it might be visible for us
00:33 - 00:35
to make use of the technology and develop human capacity
00:36 - 00:37
beyond what is normal.
00:37 - 00:40
For instance, improving muscle tissues to make it more resilient
00:40 - 00:45
and less likely to fatigue, implanting Newlands oxygenated blood more
00:45 - 00:47
efficiently, even in more polluted environment, etcetera
See full transcript